Robert Thomas Freeman Sells 38,858 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 38,858 shares of the stock in a transaction on Friday, July 19th. The shares were sold at an average price of $10.01, for a total value of $388,968.58. Following the completion of the transaction, the chief financial officer now owns 414,429 shares of the company’s stock, valued at approximately $4,148,434.29. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Robert Thomas Freeman also recently made the following trade(s):

• On Wednesday, July 17th, Robert Thomas Freeman sold 22,100 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.00, for a total value of $221,000.00.

Alignment Healthcare Stock Up 0.7 %

Shares of ALHC stock opened at $10.07 on Monday. The stock’s 50 day simple moving average is $7.92 and its 200 day simple moving average is $6.68. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.57 and a current ratio of 1.57. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $10.10. The company has a market capitalization of $1.93 billion, a price-to-earnings ratio of -11.99 and a beta of 1.43.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Thursday, May 2nd. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.01). Alignment Healthcare had a negative net margin of 7.81% and a negative return on equity of 91.06%. The company had revenue of $628.60 million during the quarter, compared to the consensus estimate of $599.75 million. During the same period in the previous year, the business posted ($0.20) earnings per share. The firm’s revenue was up 43.1% on a year-over-year basis. As a group, research analysts predict that Alignment Healthcare, Inc. will post -0.67 EPS for the current year.

Analysts Set New Price Targets

ALHC has been the subject of a number of recent analyst reports. Stephens increased their price target on Alignment Healthcare from $6.00 to $7.00 and gave the company an “equal weight” rating in a research report on Friday, May 3rd. Robert W. Baird initiated coverage on Alignment Healthcare in a research report on Thursday, May 30th. They issued an “outperform” rating and a $10.00 price target for the company. Piper Sandler upgraded Alignment Healthcare from a “neutral” rating to an “overweight” rating and increased their price target for the company from $6.00 to $8.00 in a research report on Wednesday, May 8th. Stifel Nicolaus cut their price target on Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating for the company in a research note on Tuesday, April 23rd. Finally, Baird R W raised Alignment Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $9.11.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its position in Alignment Healthcare by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 9,239,472 shares of the company’s stock worth $45,828,000 after buying an additional 93,262 shares during the period. Hood River Capital Management LLC increased its position in Alignment Healthcare by 49.6% in the 1st quarter. Hood River Capital Management LLC now owns 2,920,836 shares of the company’s stock worth $14,487,000 after buying an additional 968,637 shares during the period. Charles Schwab Investment Management Inc. increased its position in Alignment Healthcare by 1.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 751,309 shares of the company’s stock worth $6,469,000 after buying an additional 10,123 shares during the period. Assenagon Asset Management S.A. increased its position in Alignment Healthcare by 283.9% in the 1st quarter. Assenagon Asset Management S.A. now owns 315,629 shares of the company’s stock worth $1,566,000 after buying an additional 233,417 shares during the period. Finally, Blue Trust Inc. increased its position in Alignment Healthcare by 47.4% in the 1st quarter. Blue Trust Inc. now owns 256,452 shares of the company’s stock worth $1,272,000 after buying an additional 82,476 shares during the period. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.